Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem Bolus vs Prolonged Infusion in Neonatal Sepsis
NCT02503761Phase 3Completed
- Sponsor
- Mansoura University
- Start
- Aug 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of meropenem in late-onset neonatal sepsis (LONS) (2 arms), sponsored by Mansoura University. Primary endpoints: Clinical outcome and Microbiological outcome. Started Aug 2013; status: completed.
02
Drugs
meropenem
03
Conditions
late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NCT02503761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503761.